PRESSURE BIOSCIENCES INC Quarterly Return On Equity in % from Q1 2012 to Q1 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Pressure Biosciences Inc quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q1 2024.
  • Pressure Biosciences Inc Return On Equity for the quarter ending March 31, 2024 was 25.9 %, a 57.7% decline year-over-year.
  • Pressure Biosciences Inc annual Return On Equity for 2023 was 23.1 %, a 58.9% decline from 2022.
  • Pressure Biosciences Inc annual Return On Equity for 2022 was 56.2 %, a 40.7% decline from 2021.
  • Pressure Biosciences Inc annual Return On Equity for 2021 was 94.8 %, a 12.1% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 25.9 -35.3 -57.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 23.1 -33.1 -58.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 80.3 +20.7 +34.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 75.7 +7.73 +11.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 61.2 -18.6 -23.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 56.2 -38.6 -40.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 59.6 -43.1 -42% Jul 1, 2022 Sep 30, 2022
Q2 2022 67.9 -33.3 -32.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 79.9 -32.7 -29.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 94.8 -13.1 -12.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 103 -11 -9.66% Jul 1, 2021 Sep 30, 2021
Q2 2021 101 -22.7 -18.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 113 -12.1 -9.67% Jan 1, 2021 Mar 31, 2021
Q4 2020 108 -19.4 -15.2% Oct 1, 2020 Dec 31, 2020
Q3 2020 114 -34.2 -23.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 124 -28.2 -18.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 125 -42 -25.2% Jan 1, 2020 Mar 31, 2020
Q4 2019 127 +8.2 +6.88% Oct 1, 2019 Dec 31, 2019
Q3 2019 148 +32.4 +28% Jul 1, 2019 Sep 30, 2019
Q2 2019 152 +50 +48.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 167 +91.4 +121% Jan 1, 2019 Mar 31, 2019
Q4 2018 119 +39.5 +49.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 116 +99.2 +606% Jul 1, 2018 Sep 30, 2018
Q2 2018 102 +97.7 +2123% Apr 1, 2018 Jun 30, 2018
Q1 2018 75.3 +83.8 Jan 1, 2018 Mar 31, 2018
Q4 2017 79.6 +56.8 +249% Oct 1, 2017 Dec 31, 2017
Q3 2017 16.4 -62.4 -79.2% Jul 1, 2017 Sep 30, 2017
Q2 2017 4.6 -88 -95% Apr 1, 2017 Jun 30, 2017
Q1 2017 -8.48 -156 -106% Jan 1, 2017 Mar 31, 2017
Q4 2016 22.8 -125 -84.6% Oct 1, 2016 Dec 31, 2016
Q3 2016 78.7 -73.9 -48.4% Jul 1, 2016 Sep 30, 2016
Q2 2016 92.6 -102 -52.4% Apr 1, 2016 Jun 30, 2016
Q1 2016 148 -79.4 -35% Jan 1, 2016 Mar 31, 2016
Q4 2015 148 -129 -46.6% Oct 1, 2015 Dec 31, 2015
Q3 2015 153 -145 -48.8% Jul 1, 2015 Sep 30, 2015
Q2 2015 194 -105 -35% Apr 1, 2015 Jun 30, 2015
Q1 2015 227 -105 -31.6% Jan 1, 2015 Mar 31, 2015
Q4 2014 277 -33 -10.6% Oct 1, 2014 Dec 31, 2014
Q3 2014 298 +0.22 +0.07% Jul 1, 2014 Sep 30, 2014
Q2 2014 299 -83.6 -21.8% Apr 1, 2014 Jun 30, 2014
Q1 2014 332 -31.5 -8.65% Jan 1, 2014 Mar 31, 2014
Q4 2013 310 -60.7 -16.3% Oct 1, 2013 Dec 31, 2013
Q3 2013 298 -199 -40% Jul 1, 2013 Sep 30, 2013
Q2 2013 383 -313 -45% Apr 1, 2013 Jun 30, 2013
Q1 2013 364 -2.36K -86.7% Jan 1, 2013 Mar 31, 2013
Q4 2012 371 Oct 1, 2012 Dec 31, 2012
Q3 2012 497 Jul 1, 2012 Sep 30, 2012
Q2 2012 696 Apr 1, 2012 Jun 30, 2012
Q1 2012 2.73K Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.